ロード中...
Novel oral anticoagulants for atrial fibrillation
Anticoagulation therapy is effective in preventing primary and secondary thromboembolic events due to atrial fibrillation. Warfarin, which was approved by the United States in 1954, was the only long-term oral anticoagulation therapy till the approval of dabigatran in 2010, and of rivaroxaban and ot...
保存先:
| 出版年: | Singapore Med J |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Singapore Medical Association
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4678403/ https://ncbi.nlm.nih.gov/pubmed/26702159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11622/smedj.2015184 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|